...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization
【24h】

Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization

机译:卡波姆对PLGA纳米粒子的表面修饰以增强粘膜粘附和细胞内在化

获取原文
获取原文并翻译 | 示例

摘要

Mucoadhesive poly (lactic-co-glycolic acid) (PLGA) nanoparticles having a modified shell-matrix derived from polyvinyl alcohol (PVA) and Carbopol (CP), a biodegradable polymer coating, to improve the adhesion and cell transfection properties were developed, The optimum formulations utilized a CP concentration in the range of 0.05-0.2% w/v, and were formed using modified emulsion-solvent evaporation technique. The resulting CP-PLGA nanoparticles were characterized in terms of their physical and chemical properties. The absorbed CP on the PLGA shell-matrix was found to affect the particle size and surface charge, with 0.05% CP giving rise to smooth spherical particles (0.05CP-PLGA) with the smallest size (285.90 nm), and strong negative surface charge (-25.70 mV). The introduction of CP results in an enhancement of the mucoadhesion between CP-PLGA nanoparticles and mucin particles. In vitro cell internalization studies highlighted the potential of 0.05CP-PLGA nanoparticles for transfection into SiHa cells, with uptake being time dependent. Additionally, cytotoxicity studies of CP-PLGA nanoparticles against SiHa cancer cells indicated that low concentrations of the nanoparticles were non-toxic to cells (cell viability >80%). From the various formulations studied, 0.05CP-PLGA nanoparticles proved to be the optimum model carrier having the required mucoadhesive profile and could be an alternative therapeutic efficacy carrier for targeted mucosal drug delivery systems with biodegradable polymer. (C) 2015 Elsevier B.V. All rights reserved.
机译:开发了具有改性的壳聚糖的粘膜粘附性聚乳酸-乙醇酸共聚物(PLGA)纳米颗粒,该壳基质衍生自聚乙烯醇(PVA)和可生物降解的聚合物涂层Carbopol(CP),以改善粘附性和细胞转染特性。最佳配方利用CP浓度在0.05-0.2%w / v的范围内,并使用改良的乳液-溶剂蒸发技术形成。根据其物理和化学特性对所得的CP-PLGA纳米颗粒进行了表征。发现在PLGA壳矩阵上吸收的CP会影响粒径和表面电荷,其中0.05%CP会产生最小尺寸(285.90 nm)的光滑球形颗粒(0.05CP-PLGA)和强负表面电荷(-25.70 mV)。 CP的引入导致CP-PLGA纳米颗粒与粘蛋白颗粒之间的粘膜粘附性增强。体外细胞内在化研究强调了0.05CP-PLGA纳米颗粒具有转染到SiHa细胞中的潜力,其摄取是时间依赖性的。另外,CP-PLGA纳米颗粒对SiHa癌细胞的细胞毒性研究表明,低浓度的纳米颗粒对细胞无毒(细胞活力> 80%)。从研究的各种制剂中,0.05CP-PLGA纳米颗粒被证明是具有所需粘膜粘附特性​​的最佳模型载体,并且可以是具有可生物降解聚合物的靶向粘膜药物递送系统的替代治疗功效载体。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号